Emefcy signs collaboration agreements, raising Series A funds

Emefcy, a microbial fuel cell startup based in Caesarea, Israel, recently signed collaboration agreements with several potential clients. The companies will participate in Emefcy's pilot program in 2009 and will potentially have Emefcy's system installed in their plants in 2010, according to reports by the company.

Emefcy, co-founded by serial entrepreneurs Eytan Levy and Ronen Shechter, is developing the MEGAWATTER™ technology. This technology produces low cost electricity (at $0.10/kWhr) and hydrogen in a bio-electro-chemical process from wastewater treatment by leveraging Microbial Fuel Cell (MFC) technology. Emefcy's technological breakthrough is focused on the development of electrode materials and structure that feature durability, high power output and low cost.



Levy and Shechter, who previously founded wastewater treatment company AqWise, have already received venture funding from Israel Cleantech Ventures, and Greentech Media has detailed Levy's efforts to raise $3.5-5.0m in a Series A funding round. CEO Eytan Levy plans to be on the East Coast in February and March for meetings with potential investors. On February 26th, Levy will speak at a public event at MIT organized by the Boston Israel Cleantech Alliance.

Emefcy's Scientific Advisory Board includes Prof. Bruce Logan of Pennsylvania State University, Prof. Derek Lovely of the University of Massachusetts (Amherst) and Prof. Bruce Rittmann, Director of the Biodesign Institute at the University of Arizona.

More information about Emefcy's MEGAWATTER™ system and Emefcy's business plan is available in this online video, in this company presentation, and in past reports by the Jerusalem Post and Israel21c.

Related Posts:

Israel Cleantech buys 11% of AqWise

AqWise founders start new cleantech venture